Nav 1.7 blockers (Convergence Pharmaceuticals)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameNav 1.7 blockers (Convergence Pharmaceuticals)

Drug Alias Namesodium channel blocker (Convergence Pharmaceuticals)Nav blocker (Convergence Pharmaceuticals)sodium channel blockers (Convergence Pharmaceuticals)CNV-3000223CNV-3000164 +[6]

ClassificationSmall molecules

Mechanisms of ActionSodium channel protein type IX alpha subunit blockers

TargetsSodium channel protein type IX alpha subunit

Therapy Area/IndicationsPainEpilepsy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesConvergence Pharmaceuticals Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesConvergence Pharmaceuticals Ltd

Active IndicationsN/A

Inactive IndicationsPainEpilepsy

Other Information

ATC CodeN/A